Who
Howard Mayer
Director
Company insider
Files Form 4 as: Director, PepGen; Director, Entasis Therapeutics Holdings; Director, Invivyd; Director, Genocea Biosciences.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 6 Mar 2017
- Last trade
- 18 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 22 Jun 2026 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 20 Jun 2024filed 21 Jun 2024 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,667 at $0.00 | filing |
| 10 Nov 2023filed 14 Nov 2023 | PEPG PepGenoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,686 at $0.00 | filing |
| 11 Jul 2022filed 11 Jul 2022 | Entasis Therapeutics Holdingsoption or derivative | SEC FORM 4 Code J | —12,500 at $0.00 | filing |
| 11 Jul 2022filed 11 Jul 2022 | Entasis Therapeutics Holdingsoption or derivative | SEC FORM 4 Code J | —11,000 at $0.00 | filing |
| 11 Jul 2022filed 11 Jul 2022 | Entasis Therapeutics Holdings | SEC FORM 4 Code D | $61K27,500 at $2.20 | filing |
| 7 Jul 2022filed 11 Jul 2022 | Entasis Therapeutics Holdings | SEC FORM 4 Code U | $48K22,000 at $2.20 | filing |
| 22 Jun 2022filed 24 Jun 2022 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 18 Jan 2022filed 19 Jan 2022 | Entasis Therapeutics Holdings | SEC FORM 4 Code A | —27,500 at $0.00 | filing |
| 5 Aug 2021filed 9 Aug 2021 | IVVD Invivydoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,593 at $0.00 | filing |
| 16 Jul 2021filed 15 Feb 2022 | Entasis Therapeutics Holdingsoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 16 Jul 2021filed 15 Feb 2022 | Entasis Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —12,500 | filing |
| 1 Apr 2021filed 2 Apr 2021 | Entasis Therapeutics Holdings | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 18 Jun 2020filed 19 Jun 2020 | Genocea Biosciencesoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 10 Jun 2020filed 6 Oct 2020 | Entasis Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —11,000 at $0.00 | filing |
| 5 Aug 2019filed 6 Aug 2019 | Entasis Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 18 Jul 2019filed 19 Jul 2019 | Genocea Biosciencesoption or derivative | SEC FORM 4 Code A | —5,625 at $0.00 | filing |
| 21 Jun 2018filed 25 Jun 2018 | Genocea Biosciencesoption or derivative | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.